SK Life Science breaks through Covid barriers to bring epilepsy drug to market

Lutronic’s Focus on Change during the Pandemic

From Big Pharma to Startup: What are the Challenges?

The View from Olympus: How This MedTech Leader Approached the Pandemic

DENTALEZ COO Heather Trombley on Reinvigorating the Company

Seqirus Exec on Vaccine Differentiation

Zimmer Biomet VP on Covering the Territory

How Teleflex Grew its Market Value 4x in 6 Years

Admedus COO David St. Denis on Courage, Commitment and Conversation

- 1 min read

ONI Appoints Paul Scagnetti as CEO to Implement Next Chapter of Growth

Oxford, England & San Diego, CA, February 27, 2023 (Business Wire) -- ONI, the biotechnology company broadly enabling the ability to observe single molecules in living cells with its desktop Nanoimager microscopy platform, today announced that Paul Scagnetti has been appointed as the company's new CEO, effective February 27, 2023. Along with this leadership change, ONI will begin to implement a new strategy to accelerate commercial growth and expand its impact in research and discovery. Paul succeeds founding CEO, Bo Jing, who will remain with ONI as a key contributor in product development to help inspire ONI’s next innovations.

Read full article here.

Recent Posts

See All

Switch Therapeutics Launches with $52 Million to Advance First-of-its-Kind RNAi Technology

South San Francisco, CA, March 14. 2023 (Business Wire) -- Switch Therapeutics, a preclinical stage biotechnology company pioneering a new way to use RNA science to treat diseases, today announced i

Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability

San Diego, CA, March 14, 2023 (Globe Newswire) -- Medical Marijuana, Inc., a holding company with operating assets dedicated to the cannabis and hemp industries, along with portfolio investments in co

Bicara Therapeutics Announces $108M Series B Financing to Advance Dual-Action Biologics for Cancer

Cambridge, MA, March 6, 2023 (Business Wire) -- Bicara Therapeutics, a clinical-stage biotechnology company developing dual-action biologics to elicit a potent and durable anti-tumor response, today

Switch Therapeutics Launches with $52 Million to Advance First-of-its-Kind RNAi Technology

Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability

Bicara Therapeutics Announces $108M Series B Financing to Advance Dual-Action Biologics for Cancer

AskBio Announces Gustavo Pesquin as New CEO

Pfizer snaps up Seagen for $43 bln as Drugmaker extends buying spree

Chroma Medicine Secures $135M in Series B Financing to Advance Breakthrough Epigenetic Technology

ONI Appoints Paul Scagnetti as CEO to Implement Next Chapter of Growth

Pfizer in Talks to Buy Seagen for upwards of $30B

Viatris Announces Appointment of Scott A. Smith as CEO Effective April 1, 2023

Olympus extends into stents acquiring Taewoong Medical for $370M

Executive Spotlights

ONI Appoints Paul Scagnetti as CEO to Implement Next Chapter of Growth

Recent Posts

Life Science Headlines